Have a question?
Please get in touch with our team in case of any queries
THE GLOBAL SPATIAL TRANSCRIPTOMICS AND GENOMICS MARKET SIZE IS EXPECTED TO REACH USD 1.00 BILLION BY 2030 FROM USD 383.93 MILLION IN 2024, GROWING AT A CAGR OF 17.40% DURING THE FORECAST PERIOD.
The Spatial Transcriptomics And Genomics Market Size, Share, & Trends Analysis Report By
- Product Type: Consumables, Instruments, and Software
- Technology: Spatial Transcriptomics and Spatial Genomics
- Application: Translational Research and Drug Discovery & Development
- End-User: Pharma & Biotech Companies, Contract Research Organizations (CROs), and Academic & Research Institutes
- Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2024–2030.
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
SPATIAL TRANSCRIPTOMICS AND GENOMICS MARKET REPORT SCOPE
| REPORT ATTRIBUTE | DETAILS |
|---|---|
| MARKET SIZE (2030) | USD 1.00 Billion |
| MARKET SIZE (2024) | USD 383.93 Million |
| CAGR (2024-2030) | 17.40% |
| HISTORIC YEAR | 2021-2023 |
| BASE YEAR | 2024 |
| FORECAST YEAR | 2025-2030 |
| SEGMENTS BY | Product Type, Technology, Application, End-User, and Geography |
| GEOGRAPHIC ANALYSIS | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY PLAYERS | 10x Genomics, Bio-Techne, Illumina, and NanoString (Bruker Spatial Biology) |
MARKET ANALYSIS
The global spatial transcriptomics and genomics market size was valued at USD 383.93 million in 2024 and is expected to reach USD 1.00 billion by 2030, growing at a CAGR of 17.40% during the forecast period. The market is a rapidly evolving domain that integrates cutting-edge technologies to map gene expression and genomic data within the spatial context of tissues and cells. This field is witnessing significant growth due to its transformative potential in understanding complex biological systems, disease mechanisms, and personalized medicine. Furthermore, the global spatial transcriptomics and genomics market is poised for exponential growth as advancements in technology and analytical capabilities continue. With its transformative impact on research and medicine, the market is set to play a pivotal role in understanding cellular heterogeneity, developing personalized therapies, and addressing complex biological questions. However, overcoming cost and expertise-related challenges will be crucial to unlocking its full potential.
Innovations in high-resolution imaging, single-cell sequencing, and computational analysis are propelling the market forward. Techniques such as in situ hybridization and spatial transcriptomics sequencing enable researchers to map cellular processes with unprecedented precision, driving adoption across academic and clinical research sectors. Overall, the global spatial transcriptomics and genomics market is at the forefront of innovation, promising to reshape biomedical research and healthcare. Strategic investments in technology, infrastructure, and partnerships will be essential to harness its capabilities and drive future advancements.
MARKET TRENDS & DRIVERS
Increasing Use of Spatial Omics for Biomarker Identification
By enabling detailed mapping of molecular interactions within tissues, spatial omics offer a powerful approach to discovering novel biomarkers, advancing precision medicine, and improving therapeutic outcomes. With rapid technological advancements and a growing interest in personalized healthcare, the spatial transcriptomics and genomics market is positioned for substantial growth. As more researchers, pharmaceutical companies, and diagnostics firms adopt spatial omics for biomarker discovery, this emerging field will likely play a pivotal role in shaping the future of healthcare.
Emerging Potential of Spatial Genomic Analysis in Cancer Diagnosis
The emerging potential of spatial genomic analysis in cancer diagnosis represents a transformative development in the field of oncology, offering unprecedented precision in tumor profiling and personalized treatment strategies. This trend is poised to drive growth in the global spatial transcriptomics and genomics market, opening new avenues for innovation in diagnostics, biomarker discovery, and targeted therapy development. As the technology evolves and becomes more cost-effective, spatial genomics will likely play a central role in revolutionizing cancer diagnosis and treatment on a global scale.
Increasing Adoption of Spatial Genomics and Transcriptomics Technologies
With expanding applications in cancer research, neuroscience, precision medicine, and more, these technologies are revolutionizing how scientists understand biological processes. As AI and machine learning continue to enhance data analysis and as collaborations boost research capabilities, the market is expected to grow further. By addressing current challenges and building on technological advancements, spatial genomics, and transcriptomics are set to play an increasingly critical role in modern biomedical research and clinical practice, shaping the future of medicine.
Growth in Preference Toward Personalized Medicines
The preference for personalized medicine is a major driver of the global spatial transcriptomics and genomics market, highlighting the increasing need for highly specialized tools to analyze gene expression in spatial contexts. With advances in technology and a growing focus on individualized patient care, spatial techniques are poised to transform disease research, drug development, and clinical diagnostics. As spatial genomics becomes more accessible and its applications in personalized medicine expand, it will play a pivotal role in the future of healthcare, enabling treatments that are not only more effective but also more aligned with each patient’s unique genetic and cellular landscape.
Rise in Prevalence of Genetic Disorders
The rising prevalence of genetic disorders has underscored the need for innovative diagnostic and therapeutic tools, which spatial transcriptomics and genomics are well-positioned to address. By providing a detailed spatial understanding of gene expression and genetic mutations within tissues, these technologies allow researchers to delve deeper into the cellular mechanics of genetic disorders. As the spatial transcriptomics and genomics market continues to grow, driven by technological advances and the need for precision in genetic disorder research, it holds the potential to revolutionize the diagnosis, treatment, and understanding of numerous genetic diseases, offering hope for improved patient outcomes and enhanced quality of life for individuals affected by genetic disorders.
SEGMENTATION INSIGHTS
INSIGHTS BY PRODUCT TYPE
The global spatial transcriptomics and genomics market by product type is segmented into consumables, instruments, and software. Consumables include reagents, kits, slides, and other laboratory supplies necessary for spatial transcriptomics and genomics workflows. These products are crucial for sample preparation, in situ hybridization, and imaging processes. The recurring nature of consumable usage ensures a steady revenue stream, making this segment the largest contributor to the spatial transcriptomics and genomics market. Innovations in consumables, such as high-sensitivity reagents and multiplexing kits, are driving demand. Furthermore, instruments consist of high-resolution imaging systems, sequencing platforms, and advanced microscopes used to capture spatial gene expression and genomic data. Technological advancements, including automated platforms and integrated systems, are boosting their adoption. While instruments represent a significant upfront investment, they are vital for enabling cutting-edge research and clinical applications, especially in oncology and neuroscience.
INSIGHTS BY TECHNOLOGY
The global spatial transcriptomics and genomics market can be segmented by technology into spatial transcriptomics and spatial genomics, each offering unique contributions to advancing biological research and clinical applications. Spatial transcriptomics involves mapping gene expression within tissues while preserving spatial context. This technology allows researchers to study the location-specific activity of genes, making it a crucial tool for understanding complex biological systems and diseases.
Key Features
- High-resolution mapping of gene expression.
- Integration with single-cell sequencing technologies for detailed cellular insights.
- Broad applications in cancer research, neurobiology, developmental biology, and precision medicine.
Spatial genomics focuses on mapping the organization, interaction, and regulation of genetic material within the three-dimensional space of tissues and cells. It provides insights into chromosomal interactions, genome architecture, and their impact on gene expression.
Key Features
- Visualization of genome structure and chromatin organization.
- Identification of genomic interactions that influence cellular function.
- Applications in understanding epigenetics, gene regulation, and chromosomal abnormalities.
INSIGHTS BY APPLICATION
The translational research application segment holds the most prominent share of the global spatial transcriptomics and genomics market in 2024. Translational research bridges the gap between basic science and clinical practice, and spatial transcriptomics and genomics are revolutionizing this domain. These technologies provide critical insights into gene expression patterns and genomic interactions within the spatial context of tissues, enabling a deeper understanding of disease mechanisms.
Key Contributions
- Identifying biomarkers for early diagnosis and treatment monitoring.
- Understanding the molecular and cellular heterogeneity of diseases like cancer, neurological disorders, and autoimmune conditions.
- Advancing precision medicine by tailoring treatments to individual patient profiles.
Furthermore, both translational research and drug discovery & development segments represent pivotal applications driving the global spatial transcriptomics and genomics market. While translational research focuses on bridging laboratory findings to clinical practice, drug development emphasizes creating targeted therapies. The convergence of these applications positions spatial omics as a transformative force in advancing healthcare and medicine.
INSIGHTS BY END-USER
The global spatial transcriptomics and genomics market is witnessing significant growth due to its applications across various end-user segments. Each segment plays a pivotal role in advancing the adoption and development of these technologies, driving innovation in research and healthcare. The global spatial transcriptomics and genomics market by end-user is segmented into pharma & biotech companies, contract research organizations (CROs), and academic & research institutes. The pharma & biotech companies segment holds the most prominent market share in 2024. Pharmaceutical and biotechnology companies are at the forefront of adopting spatial transcriptomics and genomics technologies, leveraging their potential to revolutionize drug discovery, development, and personalized medicine. These companies, as key end-users, integrate spatially resolved omics data into their workflows to enhance their understanding of complex biological processes, improve drug efficacy, and streamline the development of targeted therapies. The global adoption of spatial transcriptomics and genomics in the pharma and biotech sectors underscores their critical role in shaping the future of medicine. These companies use the technology for various things, such as:
- Enhance Drug Discovery: Spatial omics allow for precise identification of molecular targets and cellular interactions, accelerating the discovery of novel drugs.
- Biomarker Identification: By analyzing spatial gene expression, companies can identify and validate biomarkers for disease diagnosis and therapy monitoring.
- Personalized Medicine: Spatial technologies enable the development of targeted therapies tailored to individual patient's genetic and molecular profiles.
Key drivers for adoption in this segment include the rising demand for precision medicine, growing investments in R&D, and the need for advanced tools to study complex diseases like cancer and neurological disorders. Also, CROs are increasingly integrating spatial transcriptomics and genomics into their service offerings. These organizations provide research and analytical services to pharmaceutical, biotech, and academic clients.
GEOGRAPHICAL ANALYSIS
The spatial transcriptomics and genomics market in North America is a hub of innovation and growth, propelled by advanced research capabilities, strong funding, and a focus on precision medicine. While challenges such as high costs and regulatory complexities remain, ongoing efforts to address these barriers and expand clinical applications position North America as a leader in this transformative field. With continued investment and collaboration, the region is set to unlock new frontiers in biomedical research and healthcare. Furthermore, the spatial transcriptomics and genomics market in Europe is a rapidly evolving landscape with significant potential to transform healthcare and research. Strong institutional support, technological innovation, and growing applications in precision medicine position Europe as a leader in this domain. Addressing challenges related to cost, regulation, and ethical concerns will be crucial for sustaining growth and ensuring the equitable adoption of these cutting-edge technologies across the continent.
The APAC spatial transcriptomics and genomics market is poised for substantial growth, driven by technological advancements, increasing healthcare needs, and supportive government policies. While challenges like high costs and regulatory hurdles persist, the region’s focus on innovation, international collaborations, and emerging startups will drive market expansion. As APAC continues to invest in biotechnology and precision medicine, it is set to become a key player in shaping the future of spatial genomics globally.
The spatial transcriptomics and genomics market in Latin America is poised for growth, driven by advancements in precision medicine, increasing research funding, and emerging biotech ecosystems. However, challenges such as high costs, regulatory concerns, and disparities in healthcare access must be addressed for the market to fully realize its potential. By fostering public-private partnerships, expanding regional research initiatives, and investing in workforce training, Latin American countries can position themselves as leaders in the field of spatial genomics. With the right investments and strategies, spatial transcriptomics has the potential to transform the healthcare landscape in Latin America, improving disease diagnostics, treatment outcomes, and personalized care for the region’s diverse populations. Furthermore, the spatial transcriptomics and genomics market in the Middle East & Africa is on the cusp of transformative growth. While the region faces challenges related to infrastructure, regulation, and costs, the increasing investments in healthcare and biotechnology, along with the growing demand for personalized medicine, create a conducive environment for the adoption of these technologies. With continued international collaboration and focus on training and education, the Middle East & Africa region has the potential to become a key player in the global market.
VENDOR LANDSCAPE
The global spatial transcriptomics and genomics market is highly competitive, driven by rapid advancements in technology and increasing demand for precision medicine. This dynamic market is characterized by the presence of established players, emerging startups, and ongoing innovation aimed at addressing complex biological questions through spatially resolved omics techniques. The competition is fueled by the need for advanced tools and solutions to enhance research capabilities, accelerate drug discovery, and improve diagnostics.
Companies like 10x Genomics, Bio-techne, NanoString Technologies, and Illumina are major players in the global spatial transcriptomics and genomics market that have established strong footholds through innovative technologies and comprehensive product portfolios. These leaders focus on offering robust solutions like 10x Genomics' Visium platform and NanoString's GeoMx Digital Spatial Profiler, which provide high-resolution spatial mapping of gene expression. Furthermore, strategic acquisitions, such as 10x Genomics acquiring ReadCoor and Cartana, are common to expand capabilities in spatial genomics and transcriptomics. Also, numerous startups, such as Resolve Biosciences and Spatial Genomics, are entering the spatial transcriptomics and genomics market with disruptive technologies.
SNAPSHOT
The global spatial transcriptomics and genomics market size is expected to grow at a CAGR of approximately 17.40% from 2024 to 2030.
The following factors are likely to contribute to the growth of the global spatial transcriptomics and genomics market during the forecast period:
- Increasing Adoption of Spatial Genomics and Transcriptomics Technologies
- Growth in Preference Toward Personalized Medicines
- Rise in the Prevalence of Genetic Disorders
Base Year: 2024
Forecast Year: 2025-2030
The report considers the present scenario of the global spatial transcriptomics and genomics market and its market dynamics for 2025−2030. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.
Key Company Profiles
- 10x Genomics
- Business Overview
- Product Offerings
- Key Strategies
- Key Strengths
- Key Opportunities
- Bio-Techne
- Illumina
- NanoString (Bruker Spatial Biology)
Other Prominent Vendors
- Akoya Biosciences
- Business Overview
- Product Offerings
- BioSpyder Technologies
- Cantata Bio
- Natera
- RareCyte
- Rebus Biosystems
- Resolve Biosciences GmbH
- S2 Genomics
- Seven Bridges Genomics
- Standard BioTools
- Vizgen
Segmentation by Product Type
- Consumables
- Instruments
- Software
Segmentation by Technology
- Spatial Transcriptomics
- Spatial Genomics
Segmentation by Application
- Translational Research
- Drug Discovery & Development
Segmentation by End-User
- Pharma & Biotech Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
Segmentation by Geography
- North America
- The U.S.
- Canada
- Europe
- Germany
- The U.K.
- France
- Italy
- Spain
- Switzerland
- Netherlands
- APAC
- China
- Japan
- South Korea
- India
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East & Africa
- Turkey
- South Africa
- Saudi Arabia
- UAE
Frequently Asked Questions
How big is the global spatial transcriptomics and genomics market?
What is the growth rate of the global spatial transcriptomics and genomics market?
Who are the key players in the global spatial transcriptomics and genomics market?
What are the significant trends in the spatial transcriptomics and genomics market?
Which region dominates the global spatial transcriptomics and genomics market share?
EXHIBIT 1 MARKET SIZE CALCULATION APPROACH 2024
EXHIBIT 2 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY: MARKET SHARE 2024 & 2030 (%)
EXHIBIT 3 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE: MARKET SHARE 2024 & 2030 (%)
EXHIBIT 4 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY: MARKET SHARE 2024 & 2030 (%)
EXHIBIT 5 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION: MARKET SHARE 2024 & 2030 (%)
EXHIBIT 6 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER: MARKET SHARE 2024 & 2030 (%)
EXHIBIT 7 IMPACT OF INCREASING USE OF SPATIAL OMICS FOR BIOMARKER IDENTIFICATION
EXHIBIT 8 IMPACT OF EMERGING POTENTIAL OF SPATIAL GENOMIC ANALYSIS IN CANCER DIAGNOSIS
EXHIBIT 9 IMPACT OF NEW PRODUCT LAUNCHES & DEVELOPMENTS
EXHIBIT 10 IMPACT OF INCREASING ADOPTION OF SPATIAL GENOMICS AND TRANSCRIPTOMICS TECHNOLOGIES
EXHIBIT 11 IMPACT OF GROWTH IN PREFERENCE TOWARD PERSONALIZED MEDICINES
EXHIBIT 12 IMPACT OF RISE IN PREVALENCE OF GENETIC DISORDERS
EXHIBIT 13 IMPACT OF HIGH CAPITAL INVESTMENTS
EXHIBIT 14 IMPACT OF TECHNICAL COMPLEXITY AND DATA ANALYSIS
EXHIBIT 15 IMPACT OF ETHICAL AND REGULATORY CONCERNS
EXHIBIT 16 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 17 FIVE FORCES ANALYSIS 2024
EXHIBIT 18 INCREMENTAL GROWTH BY PRODUCT TYPE 2024 & 2030
EXHIBIT 19 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024-2030: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 20 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024-2030: ABSOLUTE GROWTH (%)
EXHIBIT 21 GLOBAL CONSUMABLES SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2024-2030: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 22 GLOBAL CONSUMABLES SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021-2030 ($ MILLION)
EXHIBIT 23 GLOBAL INSTRUMENT SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2024-2030: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 24 GLOBAL INSTRUMENT SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021-2030 ($ MILLION)
EXHIBIT 25 GLOBAL SOFTWARE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2024-2030: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 26 GLOBAL SOFTWARE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021-2030 ($ MILLION)
EXHIBIT 27 INCREMENTAL GROWTH BY TECHNOLOGY 2024 & 2030
EXHIBIT 28 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024-2030: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 29 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024-2030: ABSOLUTE GROWTH (%)
EXHIBIT 30 GLOBAL SPATIAL TRANSCRIPTOMICS MARKET 2024-2030: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 31 GLOBAL SPATIAL TRANSCRIPTOMICS MARKET 2021-2030 ($ MILLION)
EXHIBIT 32 GLOBAL SPATIAL GENOMICS MARKET 2024-2030: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 33 GLOBAL SPATIAL GENOMICS MARKET 2021-2030 ($ MILLION)
EXHIBIT 34 INCREMENTAL GROWTH BY APPLICATION 2024 & 2030
EXHIBIT 35 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024-2030: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 36 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024-2030: ABSOLUTE GROWTH (%)
EXHIBIT 37 GLOBAL TRANSLATIONAL RESEARCH SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2024-2030: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 38 GLOBAL TRANSLATIONAL RESEARCH SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021-2030 ($ MILLION)
EXHIBIT 39 GLOBAL DRUG DISCOVERY & DEVELOPMENT SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2024-2030: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 40 GLOBAL DRUG DISCOVERY & DEVELOPMENT SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021-2030 ($ MILLION)
EXHIBIT 41 INCREMENTAL GROWTH BY END-USER 2024 & 2030
EXHIBIT 42 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024-2030: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 43 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024-2030: ABSOLUTE GROWTH (%)
EXHIBIT 44 GLOBAL PHARMA & BIOTECH COMPANIES SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2024-2030: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 45 GLOBAL PHARMA & BIOTECH COMPANIES SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021-2030 ($ MILLION)
EXHIBIT 46 GLOBAL CROS SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2024-2030: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 47 GLOBAL CROS SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021-2030 ($ MILLION)
EXHIBIT 48 GLOBAL ACADEMIC & RESEARCH INSTITUTES SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2024-2030: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 49 GLOBAL ACADEMIC & RESEARCH INSTITUTES SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021-2030 ($ MILLION)
EXHIBIT 50 INCREMENTAL GROWTH BY GEOGRAPHY 2024 & 2030
EXHIBIT 51 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024-2030: INCREMENTAL GROWTH ($ MILLION)
EXHIBIT 52 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024-2030: ABSOLUTE GROWTH (%)
EXHIBIT 53 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET: KEY COUNTRIES IN 2024 ($ MILLION)
EXHIBIT 54 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2024-2030: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 55 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 56 INCREMENTAL GROWTH IN NORTH AMERICA 2024 & 2030
EXHIBIT 57 US SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 58 CANADA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 59 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET: KEY COUNTRIES IN 2024 ($ MILLION)
EXHIBIT 60 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2024-2030: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 61 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 62 INCREMENTAL GROWTH IN EUROPE 2024 & 2030
EXHIBIT 63 GERMANY SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 64 UK SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 65 FRANCE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 66 ITALY SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 67 SPAIN SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 68 SWITZERLAND SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 69 NETHERLANDS SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 70 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET: KEY COUNTRIES IN 2024 ($ MILLION)
EXHIBIT 71 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2024-2030: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 72 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 73 INCREMENTAL GROWTH IN APAC 2024 & 2030
EXHIBIT 74 CHINA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 75 JAPAN SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 76 SOUTH KOREA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 77 INDIA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 78 AUSTRALIA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 79 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET: KEY COUNTRIES IN 2024 ($ MILLION)
EXHIBIT 80 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2024-2030: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 81 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 82 INCREMENTAL GROWTH IN LATIN AMERICA 2024 & 2030
EXHIBIT 83 BRAZIL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 84 MEXICO SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 85 ARGENTINA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 86 COLOMBIA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 87 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET: KEY COUNTRIES IN 2024 ($ MILLION)
EXHIBIT 88 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2024-2030: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 89 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 90 INCREMENTAL GROWTH IN MEA 2024 & 2030
EXHIBIT 91 TURKEY SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 92 SOUTH AFRICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 93 SAUDI ARABIA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 94 UAE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET 2021–2030 ($ MILLION)
EXHIBIT 95 VENDORS OFFERING SPATIAL TRANSCRIPTOMICS & GENOMICS PRODUCTS: MARKET DOMINANCE ANALYSIS
EXHIBIT 96 VENDORS OFFERING COMMERCIAL SPATIAL TRANSCRIPTOMICS & GENOMICS PRODUCTS: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 97 KEY CAVEATS
LIST OF TABLES
TABLE 1 GLOBAL CONSUMABLES SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 2 GLOBAL CONSUMABLES SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 3 GLOBAL INSTRUMENT SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 4 GLOBAL INSTRUMENT SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 5 GLOBAL SOFTWARE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 6 GLOBAL SOFTWARE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 7 GLOBAL SPATIAL TRANSCRIPTOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 8 GLOBAL SPATIAL TRANSCRIPTOMICS BY GEOGRAPHY 2024−2030 (%)
TABLE 9 GLOBAL SPATIAL GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 10 GLOBAL SPATIAL GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 11 GLOBAL TRANSLATIONAL RESEARCH SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 12 GLOBAL TRANSLATIONAL RESEARCH SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 13 GLOBAL DRUG DISCOVERY & DEVELOPMENT SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 14 GLOBAL DRUG DISCOVERY & DEVELOPMENT SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 15 GLOBAL PHARMA & BIOTECH COMPANIES SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 16 GLOBAL PHARMA & BIOTECH COMPANIES SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 17 GLOBAL CROS SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 18 GLOBAL CROS SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 19 GLOBAL ACADEMIC & RESEARCH INSTITUTES SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 20 GLOBAL ACADEMIC & RESEARCH INSTITUTES SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 21 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 ($ MILLION)
TABLE 22 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 (%)
TABLE 23 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 ($ MILLION)
TABLE 24 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 (%)
TABLE 25 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 ($ MILLION)
TABLE 26 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 (%)
TABLE 27 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 ($ MILLION)
TABLE 28 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 (%)
TABLE 29 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 ($ MILLION)
TABLE 30 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 (%)
TABLE 31 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 ($ MILLION)
TABLE 32 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 (%)
TABLE 33 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 ($ MILLION)
TABLE 34 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 (%)
TABLE 35 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 ($ MILLION)
TABLE 36 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 (%)
TABLE 37 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 ($ MILLION)
TABLE 38 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 (%)
TABLE 39 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 ($ MILLION)
TABLE 40 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 (%)
TABLE 41 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 ($ MILLION)
TABLE 42 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 (%)
TABLE 43 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 ($ MILLION)
TABLE 44 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 (%)
TABLE 45 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 ($ MILLION)
TABLE 46 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 (%)
TABLE 47 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 ($ MILLION)
TABLE 48 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 (%)
TABLE 49 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 ($ MILLION)
TABLE 50 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 (%)
TABLE 51 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 ($ MILLION)
TABLE 52 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 (%)
TABLE 53 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 ($ MILLION)
TABLE 54 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 (%)
TABLE 55 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 ($ MILLION)
TABLE 56 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 (%)
TABLE 57 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 ($ MILLION)
TABLE 58 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 (%)
TABLE 59 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 ($ MILLION)
TABLE 60 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 (%)
TABLE 61 10X GENOMICS: MAJOR PRODUCT OFFERINGS
TABLE 62 BIO-TECHNE: MAJOR PRODUCT OFFERINGS
TABLE 63 ILLUMINA: MAJOR PRODUCT OFFERINGS
TABLE 64 NANOSTRING (BRUKER SPATIAL BIOLOGY): MAJOR PRODUCT OFFERINGS
TABLE 65 AKOYA BIOSCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 66 BIOSPYDER TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 67 CANTATA BIO: MAJOR PRODUCT OFFERINGS
TABLE 68 NATERA: MAJOR PRODUCT OFFERINGS
TABLE 69 RARECYTE: MAJOR PRODUCT OFFERINGS
TABLE 70 REBUS BIOSYSTEMS: MAJOR PRODUCT OFFERINGS
TABLE 71 RESOLVE BIOSCIENCES GMBH: MAJOR PRODUCT OFFERINGS
TABLE 72 S2 GENOMICS: MAJOR PRODUCT OFFERINGS
TABLE 73 SEVEN BRIDGES GENOMICS: MAJOR PRODUCT OFFERINGS
TABLE 74 STANDARD BIO TOOLS: MAJOR PRODUCT OFFERINGS
TABLE 75 VIZGEN: MAJOR PRODUCT OFFERINGS
TABLE 76 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 ($ MILLION)
TABLE 77 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 (%)
TABLE 78 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 ($ MILLION)
TABLE 79 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 (%)
TABLE 80 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 ($ MILLION)
TABLE 81 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 (%)
TABLE 82 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 ($ MILLION)
TABLE 83 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 (%)
TABLE 84 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 ($ MILLION)
TABLE 85 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 (%)
TABLE 86 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 ($ MILLION)
TABLE 87 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY PRODUCT TYPE 2024−2030 (%)
TABLE 88 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 ($ MILLION)
TABLE 89 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 (%)
TABLE 90 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 ($ MILLION)
TABLE 91 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 (%)
TABLE 92 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 ($ MILLION)
TABLE 93 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 (%)
TABLE 94 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 ($ MILLION)
TABLE 95 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 (%)
TABLE 96 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 ($ MILLION)
TABLE 97 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 (%)
TABLE 98 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 ($ MILLION)
TABLE 99 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY TECHNOLOGY 2024−2030 (%)
TABLE 100 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 ($ MILLION)
TABLE 101 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 (%)
TABLE 102 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 ($ MILLION)
TABLE 103 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 (%)
TABLE 104 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 ($ MILLION)
TABLE 105 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 (%)
TABLE 106 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 ($ MILLION)
TABLE 107 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 (%)
TABLE 108 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 ($ MILLION)
TABLE 109 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 (%)
TABLE 110 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 ($ MILLION)
TABLE 111 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY APPLICATION 2024−2030 (%)
TABLE 112 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 ($ MILLION)
TABLE 113 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 (%)
TABLE 114 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 ($ MILLION)
TABLE 115 NORTH AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 (%)
TABLE 116 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 ($ MILLION)
TABLE 117 EUROPE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 (%)
TABLE 118 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 ($ MILLION)
TABLE 119 APAC SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 (%)
TABLE 120 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 ($ MILLION)
TABLE 121 LATIN AMERICA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 (%)
TABLE 122 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 ($ MILLION)
TABLE 123 MEA SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY END-USER 2024−2030 (%)
TABLE 124 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 125 GLOBAL SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 126 GLOBAL CONSUMABLES SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 127 GLOBAL CONSUMABLES SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 128 GLOBAL INSTRUMENT SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 129 GLOBAL INSTRUMENT SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 130 GLOBAL SOFTWARE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 131 GLOBAL SOFTWARE SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 132 GLOBAL SPATIAL TRANSCRIPTOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 133 GLOBAL SPATIAL TRANSCRIPTOMICS BY GEOGRAPHY 2024−2030 (%)
TABLE 134 GLOBAL SPATIAL GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 135 GLOBAL SPATIAL GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 136 GLOBAL TRANSLATIONAL RESEARCH SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 137 GLOBAL TRANSLATIONAL RESEARCH SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 138 GLOBAL DRUG DISCOVERY & DEVELOPMENT SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 139 GLOBAL DRUG DISCOVERY & DEVELOPMENT SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 140 GLOBAL PHARMA & BIOTECH COMPANIES SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 141 GLOBAL PHARMA & BIOTECH COMPANIES SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 142 GLOBAL CROS SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 143 GLOBAL CROS SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 144 GLOBAL ACADEMIC & RESEARCH INSTITUTES SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 ($ MILLION)
TABLE 145 GLOBAL ACADEMIC & RESEARCH INSTITUTES SPATIAL TRANSCRIPTOMICS & GENOMICS MARKET BY GEOGRAPHY 2024−2030 (%)
TABLE 146 CURRENCY CONVERSION 2018−2024
1. SCOPE & COVERAGE
1.1. MARKET DEFINITION
1.1.1. INCLUSIONS
1.1.2. EXCLUSIONS
1.1.3. MARKET ESTIMATION CAVEATS
1.2. MARKET SEGMENT COVERAGE AND DEFINITION
1.2.1. MARKET SEGMENTATION BY PRODUCT TYPE
1.2.2. MARKET SEGMENTATION BY TECHNOLOGY
1.2.3. MARKET SEGMENTATION BY APPLICATION
1.2.4. MARKET SEGMENTATION BY END-USER
1.2.5. REGIONS & COUNTRIES COVERED
1.3. MARKET DERIVATION
1.3.1. BASE YEAR
2. PREMIUM INSIGHTS
2.1. OPPORTUNITY POCKETS
2.2. OVERVIEW
3. MARKET AT A GLANCE
4. INTRODUCTION
4.1. OVERVIEW
5. MARKET OPPORTUNITIES & TRENDS
5.1. INCREASING USE OF SPATIAL OMICS FOR BIOMARKER IDENTIFICATION
5.2. EMERGING POTENTIAL OF SPATIAL GENOMIC ANALYSIS IN CANCER DIAGNOSIS
5.3. NEW PRODUCT LAUNCHES & DEVELOPMENTS
6. MARKET GROWTH ENABLERS
6.1. INCREASING ADOPTION OF SPATIAL GENOMICS AND TRANSCRIPTOMICS TECHNOLOGIES
6.2. GROWTH IN PREFERENCE TOWARD PERSONALIZED MEDICINES
6.3. RISE IN PREVALENCE OF GENETIC DISORDERS
7. MARKET RESTRAINTS
7.1. HIGH CAPITAL INVESTMENTS
7.2. TECHNICAL COMPLEXITY AND DATA ANALYSIS
7.3. ETHICAL AND REGULATORY CONCERNS
8. MARKET LANDSCAPE
8.1. MARKET OVERVIEW
8.2. MARKET SIZE & FORECAST
8.3. FIVE FORCES ANALYSIS
8.3.1. THREAT OF NEW ENTRANTS
8.3.2. BARGAINING POWER OF SUPPLIERS
8.3.3. BARGAINING POWER OF BUYERS
8.3.4. THREAT OF SUBSTITUTES
8.3.5. COMPETITIVE RIVALRY
9. PRODUCT TYPE
9.1. MARKET SNAPSHOT & GROWTH ENGINE
9.2. MARKET OVERVIEW
9.3. CONSUMABLES
9.3.1. MARKET OVERVIEW
9.3.2. MARKET SIZE & FORECAST
9.3.3. MARKET BY GEOGRAPHY
9.4. INSTRUMENTS
9.4.1. MARKET OVERVIEW
9.4.2. MARKET SIZE & FORECAST
9.4.3. MARKET BY GEOGRAPHY
9.5. SOFTWARE
9.5.1. MARKET OVERVIEW
9.5.2. MARKET SIZE & FORECAST
9.5.3. MARKET BY GEOGRAPHY
10. TECHNOLOGY
10.1. MARKET SNAPSHOT & GROWTH ENGINE
10.2. MARKET OVERVIEW
10.3. SPATIAL TRANSCRIPTOMICS
10.3.1. MARKET OVERVIEW
10.3.2. MARKET SIZE & FORECAST
10.3.3. MARKET BY GEOGRAPHY
10.4. SPATIAL GENOMICS
10.4.1. MARKET OVERVIEW
10.4.2. MARKET SIZE & FORECAST
10.4.3. MARKET BY GEOGRAPHY
11. APPLICATION
11.1. MARKET SNAPSHOT & GROWTH ENGINE
11.2. MARKET OVERVIEW
11.3. TRANSLATIONAL RESEARCH
11.3.1. MARKET OVERVIEW
11.3.2. MARKET SIZE & FORECAST
11.3.3. MARKET BY GEOGRAPHY
11.4. DRUG DISCOVERY & DEVELOPMENT
11.4.1. MARKET OVERVIEW
11.4.2. MARKET SIZE & FORECAST
11.4.3. MARKET BY GEOGRAPHY
12. END-USER
12.1. MARKET SNAPSHOT & GROWTH ENGINE
12.2. MARKET OVERVIEW
12.3. PHARMA & BIOTECH COMPANIES
12.3.1. MARKET OVERVIEW
12.3.2. MARKET SIZE & FORECAST
12.3.3. MARKET BY GEOGRAPHY
12.4. CROS
12.4.1. MARKET OVERVIEW
12.4.2. MARKET SIZE & FORECAST
12.4.3. MARKET BY GEOGRAPHY
12.5. ACADEMIC & RESEARCH INSTITUTES
12.5.1. MARKET OVERVIEW
12.5.2. MARKET SIZE & FORECAST
12.5.3. MARKET BY GEOGRAPHY
13. GEOGRAPHY
13.1. MARKET SNAPSHOT & GROWTH ENGINE
13.2. GEOGRAPHIC OVERVIEW
14. NORTH AMERICA
14.1. MARKET OVERVIEW
14.2. MARKET SIZE & FORECAST
14.2.1. PRODUCT TYPE
14.2.2. TECHNOLOGY
14.2.3. APPLICATION
14.2.4. END-USER
14.3. KEY COUNTRIES
14.4. US: MARKET SIZE & FORECAST
14.5. CANADA: MARKET SIZE & FORECAST
15. EUROPE
15.1. MARKET OVERVIEW
15.2. MARKET SIZE & FORECAST
15.2.1. PRODUCT TYPE
15.2.2. TECHNOLOGY
15.2.3. APPLICATION
15.2.4. END-USER
15.3. KEY COUNTRIES
15.4. GERMANY: MARKET SIZE & FORECAST
15.5. UK: MARKET SIZE & FORECAST
15.6. FRANCE: MARKET SIZE & FORECAST
15.7. ITALY: MARKET SIZE & FORECAST
15.8. SPAIN: MARKET SIZE & FORECAST
15.9. SWITZERLAND: MARKET SIZE & FORECAST
15.10. NETHERLANDS: MARKET SIZE & FORECAST
16. APAC
16.1. MARKET OVERVIEW
16.2. MARKET SIZE & FORECAST
16.2.1. PRODUCT TYPE
16.2.2. TECHNOLOGY
16.2.3. APPLICATION
16.2.4. END-USER
16.3. KEY COUNTRIES
16.4. CHINA: MARKET SIZE & FORECAST
16.5. JAPAN: MARKET SIZE & FORECAST
16.6. SOUTH KOREA: MARKET SIZE & FORECAST
16.7. INDIA: MARKET SIZE & FORECAST
16.8. AUSTRALIA: MARKET SIZE & FORECAST
17. LATIN AMERICA
17.1. MARKET OVERVIEW
17.2. MARKET SIZE & FORECAST
17.2.1. PRODUCT TYPE
17.2.2. TECHNOLOGY
17.2.3. APPLICATION
17.2.4. END-USER
17.3. KEY COUNTRIES
17.4. BRAZIL: MARKET SIZE & FORECAST
17.5. MEXICO: MARKET SIZE & FORECAST
17.6. ARGENTINA: MARKET SIZE & FORECAST
17.7. COLOMBIA: MARKET SIZE & FORECAST
18. MIDDLE EAST & AFRICA
18.1. MARKET OVERVIEW
18.2. MARKET SIZE & FORECAST
18.2.1. PRODUCT TYPE
18.2.2. TECHNOLOGY
18.2.3. APPLICATION
18.2.4. END-USER
18.3. KEY COUNTRIES
18.4. TURKEY: MARKET SIZE & FORECAST
18.5. SOUTH AFRICA: MARKET SIZE & FORECAST
18.6. SAUDI ARABIA: MARKET SIZE & FORECAST
18.7. UAE: MARKET SIZE & FORECAST
19. COMPETITIVE LANDSCAPE
19.1. COMPETITION OVERVIEW
19.2. MARKET SHARE ANALYSIS
19.2.1. 10X GENOMICS
19.2.2. BIO-TECHNE
19.2.3. ILLUMINA
19.2.4. NANOSTRING (A BRUKER COMPANY)
20. KEY COMPANY PROFILES
20.1. 10X GENOMICS
20.1.1. BUSINESS OVERVIEW
20.1.2. PRODUCT OFFERINGS
20.1.3. KEY STRATEGIES
20.1.4. KEY STRENGTHS
20.1.5. KEY OPPORTUNITIES
20.2. BIO-TECHNE
20.2.1. BUSINESS OVERVIEW
20.2.2. PRODUCT OFFERINGS
20.2.3. KEY STRATEGIES
20.2.4. KEY STRENGTHS
20.2.5. KEY OPPORTUNITIES
20.3. ILLUMINA
20.3.1. BUSINESS OVERVIEW
20.3.2. PRODUCT OFFERINGS
20.3.3. KEY STRATEGIES
20.3.4. KEY STRENGTHS
20.3.5. KEY OPPORTUNITIES
20.4. NANOSTRING (BRUKER SPATIAL BIOLOGY)
20.4.1. BUSINESS OVERVIEW
20.4.2. PRODUCT OFFERINGS
20.4.3. KEY STRATEGIES
20.4.4. KEY STRENGTHS
20.4.5. KEY OPPORTUNITIES
21. OTHER PROMINENT VENDORS
21.1. AKOYA BIOSCIENCES
21.1.1. BUSINESS OVERVIEW
21.1.2. PRODUCT OFFERINGS
21.2. BIOSPYDER TECHNOLOGIES
21.2.1. BUSINESS OVERVIEW
21.2.2. PRODUCT OFFERINGS
21.3. CANTATA BIO
21.3.1. BUSINESS OVERVIEW
21.3.2. PRODUCT OFFERINGS
21.4. NATERA
21.4.1. BUSINESS OVERVIEW
21.4.2. PRODUCT OFFERINGS
21.5. RARECYTE
21.5.1. BUSINESS OVERVIEW
21.5.2. PRODUCT OFFERINGS
21.6. REBUS BIOSYSTEMS
21.6.1. BUSINESS OVERVIEW
21.6.2. PRODUCT OFFERINGS
21.7. RESOLVE BIOSCIENCES GMBH
21.7.1. BUSINESS OVERVIEW
21.7.2. PRODUCT OFFERINGS
21.8. S2 GENOMICS
21.8.1. BUSINESS OVERVIEW
21.8.2. PRODUCT OFFERINGS
21.9. SEVEN BRIDGES GENOMICS
21.9.1. BUSINESS OVERVIEW
21.9.2. PRODUCT OFFERINGS
21.10. STANDARD BIO TOOLS
21.10.1. BUSINESS OVERVIEW
21.10.2. PRODUCT OFFERINGS
21.11. VIZGEN
21.11.1. BUSINESS OVERVIEW
21.11.2. PRODUCT OFFERINGS
22. REPORT SUMMARY
22.1. KEY TAKEAWAYS
22.2. STRATEGIC RECOMMENDATIONS
23. QUANTITATIVE SUMMARY
23.1. MARKET BY PRODUCT TYPE
23.1.1. NORTH AMERICA
23.1.2. EUROPE
23.1.3. APAC
23.1.4. LATIN AMERICA
23.1.5. MEA
23.2. MARKET BY TECHNOLOGY
23.2.1. NORTH AMERICA
23.2.2. EUROPE
23.2.3. APAC
23.2.4. LATIN AMERICA
23.2.5. MEA
23.3. MARKET BY APPLICATION
23.3.1. NORTH AMERICA
23.3.2. EUROPE
23.3.3. APAC
23.3.4. LATIN AMERICA
23.3.5. MEA
23.4. MARKET BY END-USER
23.4.1. NORTH AMERICA
23.4.2. EUROPE
23.4.3. APAC
23.4.4. LATIN AMERICA
23.4.5. MEA
23.5. MARKET BY GEOGRAPHY
23.5.1. CONSUMABLES
23.5.2. INSTRUMENT
23.5.3. SOFTWARE
23.5.4. SPATIAL TRANSCRIPTOMICS
23.5.5. SPATIAL GENOMICS
23.5.6. TRANSLATIONAL RESEARCH
23.5.7. DRUG DISCOVERY & DEVELOPMENT
23.5.8. PHARMA & BIOTECH COMPANIES
23.5.9. CONTRACT RESEARCH ORGANIZATIONS (CROS)
23.5.10. ACADEMIC & RESEARCH INSTITUTES
24. APPENDIX
24.1. RESEARCH METHODOLOGY
24.2. RESEARCH PROCESS
24.3. REPORT ASSUMPTIONS & CAVEATS
24.3.1. KEY CAVEATS
24.3.2. CURRENCY CONVERSION
24.4. ABBREVIATIONS
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
How big is the global spatial transcriptomics and genomics market?
What is the growth rate of the global spatial transcriptomics and genomics market?
Who are the key players in the global spatial transcriptomics and genomics market?
What are the significant trends in the spatial transcriptomics and genomics market?
Which region dominates the global spatial transcriptomics and genomics market share?
Other RELATED Reports
Global Artificial Intelligence (AI) In Genomics Market - Focused Insights 2024-2029
Published : July 2024
